USFDA completes inspection of Natco's Kothur formulation facility Medical Dialogues Bureau11 March 2020 1:07 PM ISTHyderabad: Natco Pharma Limited has announced the completion of a Pre-approval inspection from the United States Food and Drug Administration (USFDA)...
Natco Pharma net profit slips 35pc to Rs 104 crore in Q3 Medical Dialogues Bureau15 Feb 2020 10:30 AM ISTNew Delhi: Drug firm Natco Pharma on Wednesday reported a 34.46 per cent drop in consolidated net profit to Rs 104.4 crore for the quarter ended...
Natco Pharma Vizag facility begins production Medical Dialogues Bureau16 Nov 2019 9:35 AM ISTThe Visakhapatnam facility was a part of the Special Economic Zone (SEZ) and intended to cater primarily to the U.S. and other international markets,...
NPPA fixes retail price of 14 drug formulations; Details Farhat Nasim13 Nov 2019 11:23 AM ISTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
Natco Pharma Q2 profit declines to Rs 118 crore due to drop in oseltamivir product sales in US Medical Dialogues Bureau13 Nov 2019 9:33 AM IST"The decline in revenues and profits compared to the same period last year is primarily due to the anticipated drop in oseltamivir product sales in...
Natco Pharma Mekaguda facility gets EIR from USFDA Farhat Nasim1 Oct 2019 3:57 PM ISTHyderabad: Drug firm Natco Pharma today said it has received Establishment Inspection Report (EIR) from the US health regulator for its Active...
Delhi HC given Green Signal to Natco Pharma for generic of Novartis cancer drug Ceritinib Farhat Nasim1 Sept 2019 2:33 PM ISTNew Delhi: In a major relief to Natco, the Delhi High Court has lifted a ban on Natco Pharma from manufacturing fresh stock of on-small cell lung...
Natco Pharma gets 6 USFDA observations for API facility near Hyderabad Medical Dialogues Bureau13 Aug 2019 1:16 PM ISTNatco Pharma said it will provide due justifications and corrective action plan within the next 15 working days to address the USFDA observations.NEW...
Natco Pharma to focus to scale up Cancer treatment biz in China: MD VC Nannapaneni Medical Dialogues Bureau12 Aug 2019 12:26 PM ISTNew Delhi: Natco Pharma is focusing on filing of cancer treatment drugs in China, the world's second largest pharmaceutical market, as part of its...
Natco Pharma gets EIR from USFDA for Kothur facility Medical Dialogues Bureau6 Aug 2019 4:35 PM ISTNew Delhi: Drug firm Natco Pharma on Monday said it has received establishment inspection report (EIR) from the US health regulator for its Kothur...
Apixaban Patent: Natco gets HC relief for its upcoming medicine Apigat Farhat Nasim26 July 2019 3:00 PM ISTNEW DELHI: Days after ending a patent row over its cancer drug Regonat with Bayer, drugmaker, Natco Pharma is reported to have now been embroiled in a...
Natco Pharma gets zero USFDA observations for Chennai facility Medical Dialogues Bureau16 July 2019 9:30 AM ISTNatco Pharma announced "successful completion of regulatory inspection from the US Food and Drug Administration (USFDA) for its active pharmaceutical...
